Skip to main content
. 2016 Jul 4;354:i3426. doi: 10.1136/bmj.i3426

Table 3.

Costs and outcomes of each pathway (in screening population of 698 500 pregnant women), using national data

Testing strategy Screening NIPT (£250) Invasive testing Total costs (£000) DS positive IPD related miscarriage (No)
No Test positive £000 No £000 Direct No After NIPT No £000 NIPT or IPD Confirmed by IPD
Current 462 407 10 635 13 312 0 0 5743 0 3733 17 045 577 577 29
NIPT ≥1/1000 462 407 45 316 13 312 32 160 8940 2127 297 1576 23 829 833 732 12
NIPT ≥1/500 462 407 26 357 13 312 18 795 5225 2127 282 1566 20 103 814 719 12
NIPT ≥1/150 462 407 10 635 13 312 7711 2143 2127 248 1544 17 000 772 688 12
NIPT ≥1/1000—no direct IPD 462 407 45 316 13 312 34 128 9487 0 664 432 23 231 826 601 3
NIPT ≥1/500—no direct IPD 462 407 26 357 13 312 20 762 5772 0 649 422 19 506 807 587 3
NIPT ≥1/150—no direct IPD 462 407 10 635 13 312 9678 2690 0 615 400 16 403 765 556 3